Sign in

NCT04573751Completed

The EPIVER Randomized Controlled Trial

Intracoronary Administration of Epinephrine and Verapamil in the Refractory No-reflow Phenomenon in Patients With Acute Myocardial Infarction: The EPIVER Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 24 Jun 2026

Brief summary (registry, in English)

The trial aims to estimate the efficacy and safety of the intracoronary administration of adrenalin, verapamil, as well as their combination compared to standard treatment in patients with STEMI and refractory coronary no-reflow despite conventional treatment during percutaneous coronary intervention (PPCI)

Status (registry)
Completed
Study type
Interventional
Enrollment
104 (actual)
First submitted
28 Sept 2020
Start date
30 Dec 2020
Primary completion date
31 Jan 2023
Lead sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
NCT number
NCT04573751

What you commit to

  • Study type: Interventional
  • Participants enrolled: 104
  • From 30 Dec 2020 to the primary completion date, 31 Jan 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unable to undergo or contra-indications for MRI or SPECT

Who the study is looking for

  • patients with ST-elevation myocardial infarction
  • Infarct-related artery TIMI flow grade 0-2 during the interventional procedure after the initial opening of the vessel.
  • Written the informed consent to participate in research

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cardiology Research Institute, Tomsk NRMC
Coordinator of this site? Confirm its status
TomskRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.